1. Home
  2. PASG vs INUV Comparison

PASG vs INUV Comparison

Compare PASG & INUV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PASG

Passage Bio Inc.

HOLD

Current Price

$4.08

Market Cap

26.0M

Sector

Health Care

ML Signal

HOLD

Logo Inuvo Inc.

INUV

Inuvo Inc.

HOLD

Current Price

$1.84

Market Cap

27.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
PASG
INUV
Founded
2017
N/A
Country
United States
United States
Employees
27
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Advertising
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
26.0M
27.6M
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
PASG
INUV
Price
$4.08
$1.84
Analyst Decision
Buy
Strong Buy
Analyst Count
7
4
Target Price
$14.00
$11.00
AVG Volume (30 Days)
129.1K
194.2K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
50.00
EPS
N/A
N/A
Revenue
N/A
$86,209,305.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$12.89
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2.88
52 Week Low
$0.28
$0.36
52 Week High
$20.00
$6.27

Technical Indicators

Market Signals
Indicator
PASG
INUV
Relative Strength Index (RSI) 29.13 41.45
Support Level N/A $1.82
Resistance Level $8.94 $1.99
Average True Range (ATR) 0.61 0.11
MACD -0.31 -0.00
Stochastic Oscillator 2.35 24.98

Price Performance

Historical Comparison
PASG
INUV

About PASG Passage Bio Inc.

Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.

About INUV Inuvo Inc.

Inuvo Inc is an advertising technology and services company that has developed and commercialized large language generative artificial intelligence (AI) for modeling media audiences. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.

Share on Social Networks: